Methicillin-Resistant Staphylococcus Aureus Pneumonia After Thoracic Surgery: Successful Treatment With Linezolid After Failed Vancomycin Therapy

Annals of Thoracic Surgery

Volumn 83, Issue 5, 2007, Pages 1888-1891

  Salerno, Daniel ^a   Vahid, Bobbak ^a   Marik, Paul E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

AGED; ANAMNESIS; ARTICLE; BACTERIAL PNEUMONIA; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LUNG LAVAGE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; THORAX SURGERY; TREATMENT FAILURE; TREATMENT OUTCOME;

ACETAMIDES; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CROSS INFECTION; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; OXAZOLIDINONES; PNEUMONIA, STAPHYLOCOCCAL; STAPHYLOCOCCUS AUREUS; THORACIC SURGICAL PROCEDURES; TREATMENT FAILURE; TREATMENT OUTCOME; VANCOMYCIN;

EID: 34247238187     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.11.068     Document Type: Article

References (11)

1. Richards M.J., Edwards J.R., Culver D.H., et al. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21 (2000) 510-515
2. Boyce J.M., Potter-Bynoe G., Dziobek, et al. Nosocomial pneumonia in Medicare patients: hospital costs and reimbursement patterns under the prospective payment system. Arch Intern Med 151 (1991) 1109-1114
3. American Thoracic Society. Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 (2005) 388-416
4. Shorr A.F., Kunkel M.J., and Kollef M. Linezolid versus vancomycin for Staphylococcus bacteraemia: pooled analysis of randomized studies. J Antimicrob Chemother 56 (2005) 923-929
5. Jaksic B., Martinelli G., Perez-Oteyza J., et al. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer. Clin Infect Dis 42 (2006) 597-607
6. Machado A.R., Arnus Cda C., Follador W., et al. Cost-effectiveness of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus. Braz J Infect Dis 9 (2005) 191-200
7. Lamer C., de Beco V., Soler P., et al. Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob Agents Chemother 37 (1993) 281-286
8. Conte Jr. J.E., Golden J.A., Kipps J., and Zurlinden E. Intrapulmonary pharmacokinetics of Linezolid. Antimicrob Agents Chemother 46 (2002) 1475-1480
9. Rubinstein E., Cammarata S., Oliphant T., et al., Linezolid Nosocomial Pneumonia Study Group. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 32 (2001) 402-412
10. Wunderink R.G., Cammarata S.K., Oliphant T.H., et al., Linezolid Nosocomial Pneumonia Study Group. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther 25 (2003) 980-992
11. Wunderink R.G., Rello J., Cammarata S.K., et al. Linezolid vs. vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124 (2003) 1789-1797